Sort   by:  
 Page size 
MetabolomicsDeep Metabolomics of a High-Grade Serous Ovarian Cancer Triple Knockout Mouse Model.
Not available
ORGANISM(S): Mus musculus 
ST001172 | MetabolomicsWorkbench
MetabolomicsMetabolomic Fingerprinting of Human High Grade Serous Ovarian Carcinoma Cell Lines
Not available
ORGANISM(S): Homo sapiens 
ST001983 | MetabolomicsWorkbench
MetabolomicsTime-Resolved Metabolomics of a Mouse Model of High-Grade Serous Ovarian Cancer (MSI)
Not available
ORGANISM(S): Mus musculus 
ST002083 | MetabolomicsWorkbench
MetabolomicsTime-Resolved Metabolomics of a Mouse Model of Ovarian High-Grade Serous Carcinoma (LC-MS)
Not available
ORGANISM(S): Mus musculus 
ST002067 | MetabolomicsWorkbench
MetabolomicsSphingosine-1-phosphate receptor 1 promotes ovarian cancer tumorsphere proliferation and metastasis
Despite extensive clinical endeavors to enhance high-grade serous ovarian cancer (HGSOC) detection and treatment, an alarming half of diagnosed women succumb annually to this disease. Significantly, nearly all HGSOC cases manifest ascites at diagnosis, a poor prognostic indicator. Malignant ascites ...
2026-03-04 | MTBLS13770 | MetaboLights
TranscriptomicsImmune-activation as a therapeutic direction for patients with high-risk ovarian cancer based on gene expression signature (2)
Advanced-stage ovarian cancer is one of the most lethal gynecologic malignancies. To improve prognosis of patients with ovarian cancers, a predictive biomarkers leading to personalized treatments are required. In this large-scale cross-platform study of six microarray datasets consisting of 1054 ova...
ORGANISM(S): Homo sapiens 
2012-03-01 | E-GEOD-32063 | biostudies-arrayexpress
TranscriptomicsImmune-activation as a therapeutic direction for patients with high-risk ovarian cancer based on gene expression signature (1)
The Japanese Serous Ovarian Cancer Study Group Advanced-stage ovarian cancer is one of the most lethal gynecologic malignancies. To improve prognosis of patients with ovarian cancers, a predictive biomarkers leading to personalized treatments are required. In this large-scale cross-platform study of...
ORGANISM(S): Homo sapiens 
2012-03-01 | E-GEOD-32062 | biostudies-arrayexpress
TranscriptomicsmiRNA profiling in high-grade serous ovarian carcinoma
In this study, we performed miRNA profiles analysis of high-grade serous ovarian carcinoma compared to normal fallopian tube fimbria using microarray (Exiqon, Denmark) to evaluate their potential role in the pathogenesis of uterine leiomyoma. miRNA profiling analysis of the 10 samples including 5 h...
ORGANISM(S): Homo sapiens 
2014-11-14 | E-GEOD-61485 | biostudies-arrayexpress
TranscriptomicsProfiles of genomic instability in high-grade serous ovarian cancer (HGSC) predict treatment outcome
Profiling of loss of heterozygosity (LOH) in HGSC, subcrouping HGSC by LOH-based clustering and comparing to the LOH profiles of triple-negative breast cancer [previously submitted; GSE19594]. Study for the correlation of LOH burdern and LOH-based subgroups to clinical response to platinum-based ch...
ORGANISM(S): Homo sapiens 
2012-11-06 | E-GEOD-39130 | biostudies-arrayexpress
TranscriptomicsA cancer associated fibroblasts (CAFs) specific gene signature in high grade serous ovarian cancer
Ovarian cancer is the most lethal malignancy in the United States. In the year 2012, there will be an estimated 22,280 new cases and 15,500 deaths from ovarian cancer in the country (Siegel et al., 2012). While studies on ovarian cancer pathogenesis were mainly focused on the epithelial component of...
ORGANISM(S): Homo sapiens 
2014-09-11 | E-GEOD-40595 | biostudies-arrayexpress
Sort   by:  
 Page size